Advertisement

Topics

FDA Clears Way for Filing on Psych Drug From Intra-Cellular, Shares Climb

09:04 EDT 23 Aug 2017 | Xconomy

The FDA has just lowered a key barrier standing between Intra-Cellular Therapies and potential approval of an experimental schizophrenia drug. Now the question is whether the mixed set of data the company has accrued to support the program will be good enough for regulators. Intra-Cellular (NASDAQ: ITCI) said the FDA has finished looking over responses […]

Original Article: FDA Clears Way for Filing on Psych Drug From Intra-Cellular, Shares Climb

NEXT ARTICLE

More From BioPortfolio on "FDA Clears Way for Filing on Psych Drug From Intra-Cellular, Shares Climb"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mental Health
Adhd Anorexia Depression Dyslexia Mental Health Psychiatry Schizophrenia Stress Mental health, although not being as obvious as physical health, is very important, causing great unhappiness to those affected, causing add...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...